Pharmacokinetics of ceftazidime in patients with biliary tract disease (Q50180575)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Pharmacokinetics of ceftazidime in patients with biliary tract disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

Pharmacokinetics of ceftazidime in patients with biliary tract disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

R A Walstad

1

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

J N Wiig

2

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

E Thurmann-Nielsen

3

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

T B Halvorsen

4

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

31

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

3

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

327-331

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and tissue penetration of ceftazidime: studies on lymph, aqueous humour, skin blister, cerebrospinal and pleural fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bacteriological investigation of the biliary system and liver in biliary tract disease correlated to clinical data and microstructure of the gallbladder and liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic Treatment of Biliary Sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative study of the effects of ceftazidime compared with tobramycin plus cefamandole in the treatment of gall bladder empyema

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic tissue concentrations: methodological aspects and interpretation of results

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The evaluation of ceftazidime in the treatment of bacterial infections in eighty seriously ill patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotics in bile

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assay of ceftazidime in biological fluids using high-pressure liquid chromatography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in-vitro properties of ceftazidime

1 reference

https://pubmed.ncbi.nlm.nih.gov/3539624

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00981132

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 February 2018

http://europepmc.org/abstract/MED/3539624

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50180575&oldid=2244731134"